|
C4ORF42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.2252646653983E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62470037423645E-12 |
| Normal-vs-Stage2 |
5.775700E-03 |
| Normal-vs-Stage3 |
8.569100E-04 |
| Normal-vs-Stage4 |
1.056660E-03 |
| Stage1-vs-Stage2 |
1.069900E-02 |
| Stage1-vs-Stage3 |
2.12909999999233E-05 |
| Stage1-vs-Stage4 |
8.002300E-04 |
| Stage2-vs-Stage3 |
6.149800E-01 |
| Stage2-vs-Stage4 |
8.249800E-01 |
| Stage3-vs-Stage4 |
7.537400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.73410199930413E-11 |
| Normal-vs-AfricanAmerican |
3.57330000000378E-06 |
| Normal-vs-Asian |
2.910300E-02 |
| Caucasian-vs-AfricanAmerican |
2.677800E-01 |
| Caucasian-vs-Asian |
3.019200E-01 |
| AfricanAmerican-vs-Asian |
5.880600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55099996682162E-09 |
| Normal-vs-Female |
3.83115761337649E-12 |
| Male-vs-Female |
3.307800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.004500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.53010978624025E-12 |
| Normal-vs-Age(61-80Yrs) |
2.08799999512621E-09 |
| Normal-vs-Age(81-100Yrs) |
1.803400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.995400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.206000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.030400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.839040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.177900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.259800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.39674946556079E-12 |
| Normal-vs-Grade 2 |
1.62936331093988E-12 |
| Normal-vs-Grade 3 |
3.07249999997872E-07 |
| Normal-vs-Grade 4 |
5.320100E-02 |
| Grade 1-vs-Grade 2 |
9.560100E-04 |
| Grade 1-vs-Grade 3 |
3.72889999999959E-06 |
| Grade 1-vs-Grade 4 |
5.13419999847997E-08 |
| Grade 2-vs-Grade 3 |
1.080760E-03 |
| Grade 2-vs-Grade 4 |
7.7962000000209E-07 |
| Grade 3-vs-Grade 4 |
3.206400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.979900E-04 |
| ccA subtype-vs-ccB subtype |
3.1430000002608E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.97349963832517E-10 |
| Normal-vs-N1 |
3.916200E-01 |
| N0-vs-N1 |
1.941040E-01 |
|
|
